| Autor: |
Andersen, KM, Cheah, JTL, March, L, Bartlett, SJ, Beaton, D, Bingham III, CO, Brooks, PM, Christensen, R, Conaghan, PG, D'Agostino, M-A, de Wit, M, Dueck, A, Goodman, SM, Grosskleg, S, Hill, CL, Howell, M, Mackie, SL, Richards, B, Shea, B, Singh, JA, Strand, V, Tugwell, P, Wells, GA, Simon, LS |
| Jazyk: |
angličtina |
| Rok vydání: |
2019 |
| ISSN: |
0315-162X |
| Popis: |
Objective: Outcome Measures in Rheumatology (OMERACT) convened a premeeting in 2018 to bring together patients, regulators, researchers, clinicians, and consumers to build upon previous OMERACT drug safety work, with patients fully engaged throughout all phases. Methods: Day 1 included a brief introduction to the history of OMERACT and methodology, and an overview of current efforts within and outside OMERACT to identify patient-reported medication safety concerns. On Day 2, two working groups presented results; after each, breakout groups were assembled to discuss findings. Results: Five themes pertaining to drug safety measurement emerged. Conclusion: Current approaches have failed to include data from the patient’s perspective. A better understanding of how individuals with rheumatic diseases view potential benefits and harms of therapies is essential. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
